Covered recipient · General Payments record
ERIC C CHENWORTH
Allopathic & Osteopathic Physicians Allergy & Immunology
General Payments · PY2023
$124.04
- Reported across 7 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $124.04 | 7 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $20.15 | 1 |
| Genentech USA, Inc. | $19.97 | 1 |
| Blueprint Medicines Corporation | $19.55 | 1 |
| Incyte Corporation | $17.95 | 1 |
| Hikma Pharmaceuticals USA | $17.04 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.87 | 1 |
| Amgen Inc. | $14.51 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $124.04 | 7 |
Payment records · PY2023 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.51 | 06/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019904193 | CMS |
| Blueprint Medicines Corporation | $19.55 | 09/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051280845 | CMS |
| Genentech USA, Inc. | $19.97 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040358527 | CMS |
| GENZYME CORPORATION | $20.15 | 08/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050360329 | CMS |
| Hikma Pharmaceuticals USA | $17.04 | 11/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053751371 | CMS |
| Incyte Corporation | $17.95 | 08/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044172155 | CMS |
| Novartis Pharmaceuticals Corporation | $14.87 | 08/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 991863393 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.